All News #Library
Rare Diseases
First Patient Dosed in Senhwa`s NCI-Sponsored Pidnarulex
15 Jul 2025 //
PR NEWSWIRE
Senhwa Biosciences Reports Positive Data from Silmitasertib Trial
02 Apr 2025 //
PR NEWSWIRE
FDA Grants RPD Designation To Senhwa`s Silmitasertib For Neuroblastoma
12 Sep 2024 //
PR NEWSWIRE

Market Place
Sourcing Support